Zev A. Wainberg, Eric Van Cutsem, Thorsten Götze, Mehmet Ali Nahit Şendur, Yousuf Al-Farhat, Piotr Jan Wysocki, Wasat Mansoor, Michael Bitzer, Vitalii Skoropad, Felipe Rey, Do-Youn Oh, Moishe Liberman, Daniela Molena, Kei Muro, Woo Jin Hyung, Lin-Yang Cheng, Francisco Hernandorena, Scott Robbins, Yelena Y. Janjigian, Josep Tabernero. "Efficacy of durvalumab and safety by treatment period in MATTERHORN: A randomized, phase 3 study of durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in resectable gastric/gastroesophageal junction (G/GEJ) cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4070